Business Description

Description
Saniona AB researches and develops drugs for the treatment of diseases of the central nervous system, autoimmune diseases, metabolic diseases, and the treatment of pain. It develops a technology platform that enables the investigation of all types of ion channel drug targets. Its research is focused on GABAA receptors, nicotinic acetylcholine receptors, and potassium channels. The company product pipeline includes Tesomet, SAN711, Tesofensine, SAN903, and SAN2219.
Name Current Vs Industry Vs History
Cash-To-Debt 0.43
Equity-to-Asset -0.34
Debt-to-Equity -3.26
Debt-to-EBITDA -0.87
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -21.14
Distress
Grey
Safe
Beneish M-Score -3.44
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.43
9-Day RSI 53.91
14-Day RSI 53.47
6-1 Month Momentum % -71.11
12-1 Month Momentum % -73.1

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.55
Quick Ratio 2.55
Cash Ratio 1.75
Days Sales Outstanding 79.88
Days Payable 915.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.9
Shareholder Yield % 8.36

Financials (Next Earnings Date:2024-05-29)

STU:30S's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Saniona AB Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 1.464
EPS (TTM) (€) -0.111
Beta 0.2
Volatility % 66.89
14-Day RSI 53.47
14-Day ATR (€) 0.005574
20-Day SMA (€) 0.15404
12-1 Month Momentum % -73.1
52-Week Range (€) 0.1408 - 0.91187
Shares Outstanding (Mil) 111.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Saniona AB Filings

Filing Date Document Date Form
No Filing Data

Saniona AB Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Saniona AB Frequently Asked Questions

What is Saniona AB(STU:30S)'s stock price today?
The current price of STU:30S is €0.16. The 52 week high of STU:30S is €0.91 and 52 week low is €0.14.
When is next earnings date of Saniona AB(STU:30S)?
The next earnings date of Saniona AB(STU:30S) is 2024-05-29.
Does Saniona AB(STU:30S) pay dividends? If so, how much?
Saniona AB(STU:30S) does not pay dividend.

Press Release

Subject Date
No Press Release